BioSpace News Archive

Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog semiconductors connecting people, places and things, today announced that executives will participate in a Fireside Chat at the Citi 2020 Global Technology Conference at 4:15 p.m. EDT on Sept. 8, 2020.

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced the appointment of two new executives, Lisa M. Olson, Ph.D., as Chief Scientific Officer and Kevin B. Johnson, Ph.D., as Senior Vice President, Head of Regulatory and Quality. The Company also announced that Jason Ryan will transition fro

Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced that members of its management team will participate in presentations and meetings with institutional investors at the following conferences

BioVentrix, Inc. , developer of the first hybrid transcatheter device for left ventricular remodeling after a heart attack, today announced that the Company has resumed cases in the pivotal ALIVE Trial studying Less Invasive Ventricular Enhancement, or LIVE™ Therapy, using the Revivent TC™ Transcatheter Ventricular Enhancement System. The first patient procedures completed since elective procedures were paused due to

Twist Bioscience Corporation (Nasdaq: TWST) today announced data demonstrating the potent neutralizing effects of multiple potential therapeutic antibodies, both Immunoglobulin G (IgG) antibodies and substantially smaller single domain VHH “nanobodies,” against SARS-CoV-2, the virus

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company has entered into a Clinical Trial Agreement (CTA), dated August 28, 2020, with the Board of Regents of the University of Wisconsin System (UWS) to conduct a clinical study entitled, “Phase I Study of the Safet

Dr. Gannon will oversee and manage regulatory matters for the Company’s upcoming clinical trials, including its lead drug candidate in combination with Tagrisso® for which Fast Track Designation was received earlier this year

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system disorders, announced that it will participate in Citi’s 15th Annual BioPharma Virtual Conference on September 9, 2020 at 1:30 p.m. Eastern Time.

ARTMS Inc., the global leader in the development and commercialization of technologies that are transforming the production of the world’s most-used diagnostic imaging isotopes, announced that it has expanded its senior management team with the addition of two industry veterans, Doug Gentilcore as Chief Commercial Officer and Mark Przekop as Vice President of Marketing and Business Development.

Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at an upcoming financial conference